Carregant...
Systemic treatments for metastatic cutaneous melanoma
BACKGROUND: The prognosis of people with metastatic cutaneous melanoma, a skin cancer, is generally poor. Recently, new classes of drugs (e.g. immune checkpoint inhibitors and small‐molecule targeted drugs) have significantly improved patient prognosis, which has drastically changed the landscape of...
Guardat en:
| Publicat a: | Cochrane Database Syst Rev |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Ltd
2018
|
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6491081/ https://ncbi.nlm.nih.gov/pubmed/29405038 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011123.pub2 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|